Press release
Sarcoma Drug Market Increasing Demand, Growth Analysis and Future Outlook by 2031
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sarcoma-drug-market
Further, in November 2021, Aadi Bioscience's Fyarro, its first commercial product, was approved by the FDA for adults with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors. The FDA approved Fyarro based on data from a phase 2 registrational trial, with 29.9% of patients achieving an overall response.
Furthermore, in February 2020, Epizyme's Tazverik, a first-in-class EZH2 inhibitor, was approved for treating epithelioid sarcoma (ES), a rare soft tissue tumor. The drug, which is expected to gain market value through wider use in more lucrative cancer settings, is expected to be available in the US for approximately 300 patients.
Global Sarcoma Drug Market Report Segment
By Treatment Type
Chemotherapy
Targeted Therapy
Immunotherapy
Others (Radiation Therapy)
By Disease Indication
Soft Tissue Sarcoma (STS)
Bone Sarcoma
Gastrointestinal Stromal Tumors (GIST)
Kaposi Sarcoma
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
A full report of Sarcoma Drug Market available @ https://www.omrglobal.com/industry-reports/sarcoma-drug-market
Sarcoma Drug Market Report Segment by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
Company Profiles
AbbVie Inc.
Adaptimmune Ltd.
Arcus Biosciences, Inc.
AstraZeneca Plc
Bristol Myers Squibb Co.
Eisai Co., Ltd.
Hoffmann-La Roche Ltd.
Fresenius Kabi AG
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Reasons to Buying From us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcoma Drug Market Increasing Demand, Growth Analysis and Future Outlook by 2031 here
News-ID: 3625683 • Views: …
More Releases from Orion Markert Research
Burn Care Market Comprehensive Research Study, Business Overview and Regional Fo …
The Burn Care Market was valued at USD 2.9 billion in 2024 and is projected to reach approximately USD 5.3 billion by 2033, growing at a CAGR of 6.8% from 2025 to 2033.
Burn Care Market Overview:
The Burn Care Market is witnessing steady growth due to the rising incidence of burn injuries, especially in low- and middle-income countries, and the increasing demand for advanced wound care products. Innovations in biologics, skin…
EConsent in Healthcare Market Set to Witness Significant Growth by 2033 | Entrat …
The global eConsent in Healthcare market was valued at approximately USD 519.4 million in 2024 and is projected to grow to around USD 1.35 billion by 2033, exhibiting a consistent CAGR of about 11.2% from 2025 to 2033.
eConsent in Healthcare Market Overview
The eConsent in Healthcare Market is expanding rapidly as healthcare providers transition from paper-based forms to digital consent solutions, leveraging mobile and cloud technologies to streamline patient onboarding and…
Battery Cell Market Size Future Scope, Demands and Projected Industry Growths to …
The Battery Cell Market is estimated to be valued at USD 96.4 billion in 2024 and is projected to reach approximately USD 312.8 billion by 2033, growing at a CAGR of 14.1% from 2025 to 2033.
Battery Cell Market Overview:
The battery cell market is experiencing robust growth driven by the rising demand for electric vehicles, renewable energy storage systems, and portable electronics. Lithium-ion cells continue to dominate the market due to…
Indoor Entertainment Center Market Size Future Scope, Demands and Projected Indu …
In 2024, the global Indoor Entertainment Center Market was valued at approximately USD 30.3 billion and is projected to reach around USD 70.3 billion by 2033, growing at a CAGR of about 9.8% from 2025 to 2033.
Indoor Entertainment Center Market Overview
The Indoor Entertainment Center Market is witnessing strong growth driven by increasing consumer demand for immersive and family-friendly recreational experiences. Factors such as rising disposable income, urbanization, and the popularity…
More Releases for Sarcoma
Emerging Trends Influencing The Growth Of The Sarcoma Drugs Market:Innovative Ge …
The Sarcoma Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Sarcoma Drugs Market Size Expected to Be by 2034?
The Sarcoma Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Key Influencer in the Sarcoma Drugs Market 2025: Surging Soft Tissue Sarcoma Cas …
What combination of drivers is leading to accelerated growth in the sarcoma drugs market?
The sarcoma drugs market is projected to grow due to an increase in soft tissue sarcoma cases. Soft tissue sarcoma is a type of cancer that originates in the body's soft tissues, such as muscles, fats, tendons, lymph, and nerves. Sarcoma drugs, widely utilized in the healthcare sector, treat bone and soft tissue sarcoma by targeting cancer…
Sarcoma Drugs Market Report 2024 - Sarcoma Drugs Market Growth, Trends, And Fore …
"The Business Research Company recently released a comprehensive report on the Global Sarcoma Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The sarcoma drugs market size…
Alveolar Soft Part Sarcoma Market - Unleashing Progress: Alveolar Soft Part Sarc …
Newark, New Castle, USA: The "Alveolar Soft Part Sarcoma Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Alveolar Soft Part Sarcoma Market: https://www.growthplusreports.com/report/alveolar-soft-part-sarcoma-market/8620
This latest report researches the…
Kaposi Sarcoma Treatment Market Drivers
Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma…
Kaposi Sarcoma Market Research Report 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
